CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on enhancing cancer immunotherapy for melanoma patients by utilizing gut microbiota. It aims to develop a diagnostic tool to identify potential responders and engineer gut bacteria to boost immune responses, potentially improving treatment outcomes for patients who currently do not respond to exist…
Cancer immunotherapy has transformed oncology, offering new hope to patients with advanced cancers such as melanoma.
However, approximately 40% of melanoma patients do not respond to current immunotherapies, highlighting the urgent need for predictive biomarkers and therapies that can increase the response and convert “non-responder” patients into “responders”.
Emerging evidence indicates that the functionality of the gut microbiota plays a critical role in modulating immune responses. A common…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
